n-acetyl bpc-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase Peptide BPC-157(HEXADECAPEPTIDE) | Synthagen –

Its independent test results load as images and PDF files

5 mg vial + 1 mL bacteriostatic water = 5 mg/mL 2 mg dose = 0.4 mL (40 units on a standard insulin syringe) 2.5 mg dose = 0.5 mL (50 units) 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL 2 mg dose = 0.8 mL (80 units) 2.5 mg dose = 1 mL (100 units, full syringe) 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL 2 mg dose = 0.4 mL (40 units) 2.5 mg dose = 0.5 mL (50 units) 5 mg dose = 1.0 mL (100 units) Most people stick with the 1 mL per 5 mg ratio because the numbers come out clean and easy to draw

(1993), while BPC-157 derives from gastric proteins, it does not share homology with any known gastric peptides [1, 2]

Each lot of BPC-157 is independently tested

The elevated concentration provides enhanced therapeutic effects through increased growth factor expression, accelerated angiogenesis, and more robust anti-inflammatory action

Hydroxocobalamin injections are resumed twice weekly (self-administrated) because of the severity of the neuropathy